{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:41:31Z","timestamp":1792269691696,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The incidence of melanoma is increasing over the years with a still poor prognosis and the lack of a cure able to guarantee an adequate survival of patients. Although the new immuno-based coupled to target therapeutic strategy is encouraging, the appearance of targeted\/cross-resistance and\/or side effects such as autoimmune disorders could limit its clinical use. Alternative therapeutic strategies are therefore urgently needed to efficiently kill melanoma cells. Ferroptosis induction and execution were evaluated in metastasis-derived wild-type and oncogenic BRAF melanoma cells, and the process responsible for the resistance has been dissected at molecular level. Although efficiently induced in all cells, in an oncogenic BRAF- and ER stress-independent way, most cells were resistant to ferroptosis execution. At molecular level we found that: resistant cells efficiently activate NRF2 which in turn upregulates the early ferroptotic marker CHAC1, in an ER stress-independent manner, and the aldo-keto reductases AKR1C1\u2009\u00f7\u20093 which degrades the 12\/15-LOX-generated lipid peroxides thus resulting in ferroptotic cell death resistance. However, inhibiting AKRs activity\/expression completely resensitizes resistant melanoma cells to ferroptosis execution. Finally, we found that the ferroptotic susceptibility associated with the differentiation of melanoma cells cannot be applied to metastatic-derived cells, due to the EMT-associated gene expression reprogramming process. However, we identified SCL7A11 as a valuable marker to predict the susceptibility of metastatic melanoma cells to ferroptosis. Our results identify the use of pro-ferroptotic drugs coupled to AKRs inhibitors as a new valuable strategy to efficiently kill human skin melanoma cells.<\/jats:p>","DOI":"10.1038\/s41419-019-2143-7","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T13:03:19Z","timestamp":1574946199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":161,"title":["Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis"],"prefix":"10.1038","volume":"10","author":[{"given":"Mara","family":"Gagliardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Cotella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Cor\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nickolai A.","family":"Barlev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Piacentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6246-5968","authenticated-orcid":false,"given":"Marco","family":"Corazzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,28]]},"reference":[{"key":"2143_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(05)70937-5","volume":"365","author":"JF Thompson","year":"2005","unstructured":"Thompson, J. F., Scolyer, R. A. & Kefford, R. F. Cutaneous melanoma. Lancet (London, England) 365, 687\u2013701 (2005).","journal-title":"Lancet (London, England)"},{"key":"2143_CR2","doi-asserted-by":"crossref","unstructured":"Corazzari, M., Fimia, G. M., Lovat, P. & Piacentini, M. Why is autophagy important for melanoma? Molecular mechanisms and therapeutic implications. Semin. Cancer Biol. 23, 337\u2013343 (2013).","DOI":"10.1016\/j.semcancer.2013.07.001"},{"key":"2143_CR3","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1200\/JCO.2006.06.0442","volume":"25","author":"LA Fecher","year":"2007","unstructured":"Fecher, L. A., Cummings, S. D., Keefe, M. J. & Alani, R. M. Toward a molecular classification of melanoma. J. Clin. Oncol. 25, 1606\u20131620 (2007).","journal-title":"J. Clin. Oncol."},{"key":"2143_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/sj.bjc.6606030","volume":"104","author":"H-T Arkenau","year":"2011","unstructured":"Arkenau, H.-T., Kefford, R. & Long, G. V. Targeting BRAF for patients with melanoma. Br. J. Cancer 104, 392\u2013398 (2011).","journal-title":"Br. J. Cancer"},{"key":"2143_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/35051606","volume":"409","author":"MS Soengas","year":"2001","unstructured":"Soengas, M. S. et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409, 207\u2013211 (2001).","journal-title":"Nature"},{"key":"2143_CR6","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1002\/cncr.30593","volume":"123","author":"BY Reddy","year":"2017","unstructured":"Reddy, B. Y., Miller, D. M. & Tsao, H. Somatic driver mutations in melanoma. Cancer 123, 2104\u20132117 (2017).","journal-title":"Cancer"},{"key":"2143_CR7","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","volume":"367","author":"KT Flaherty","year":"2012","unstructured":"Flaherty, K. T. et al. Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations. N. Engl. J. Med. 367, 1694\u20131703 (2012).","journal-title":"N. Engl. J. Med."},{"key":"2143_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1158\/1535-7163.MCT-10-0799","volume":"10","author":"ER Cantwell-Dorris","year":"2011","unstructured":"Cantwell-Dorris, E. R., O\u2019Leary, J. J. & Sheils, O. M. BRAFV600E: implications for carcinogenesis and molecular therapy. Mol. Cancer Ther. 10, 385\u2013394 (2011).","journal-title":"Mol. Cancer Ther."},{"key":"2143_CR9","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s00018-011-0878-0","volume":"69","author":"A-H Aguissa-Tour\u00e9","year":"2012","unstructured":"Aguissa-Tour\u00e9, A.-H. & Li, G. Genetic alterations of PTEN in human melanoma. Cell. Mol. Life Sci. 69, 1475\u20131491 (2012).","journal-title":"Cell. Mol. Life Sci."},{"key":"2143_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.hoc.2009.04.001","volume":"23","author":"N Dhomen","year":"2009","unstructured":"Dhomen, N. & Marais, R. BRAF signaling and targeted therapies in melanoma. Hematol. Oncol. Clin. North Am. 23, 529\u2013545 (2009).","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"2143_CR11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1600-0560.2009.01359.x","volume":"37","author":"R Lazova","year":"2010","unstructured":"Lazova, R., Klump, V. & Pawelek, J. Autophagy in cutaneous malignant melanoma. J. Cutan. Pathol. 37, 256\u2013268 (2010).","journal-title":"J. Cutan. Pathol."},{"key":"2143_CR12","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1158\/1078-0432.CCR-10-2372","volume":"17","author":"X-H Ma","year":"2011","unstructured":"Ma, X.-H. et al. Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma. Clin. Cancer Res. 17, 3478\u20133489 (2011).","journal-title":"Clin. Cancer Res."},{"key":"2143_CR13","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/cdd.2014.183","volume":"22","author":"M Corazzari","year":"2015","unstructured":"Corazzari, M. et al. Oncogenic BRAF induces chronic ER stress condition resulting in increased basal autophagy and apoptotic resistance of cutaneous melanoma. Cell Death Differ. 22, 946\u2013958 (2015).","journal-title":"Cell Death Differ."},{"issue":"8","key":"2143_CR14","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1158\/1078-0432.CCR-10-3003","volume":"17","author":"J. L. Armstrong","year":"2011","unstructured":"Armstrong, J. L. et al. Oncogenic B-RAF signaling in melanoma impairs the therapeutic advantage of autophagy inhibition. Clin. Cancer Res. 17, 2216\u20132226 (2011).","journal-title":"Clinical Cancer Research"},{"key":"2143_CR15","doi-asserted-by":"publisher","DOI":"10.4161\/23723556.2014.995016","volume":"2","author":"P Giglio","year":"2015","unstructured":"Giglio, P., Fimia, G. M., Lovat, P. E., Piacentini, M. & Corazzari, M. Fateful music from a talented orchestra with a wicked conductor: connection between oncogenic BRAF, ER stress, and autophagy in human melanoma. Mol. Cell. Oncol. 2, e995016 (2015).","journal-title":"Mol. Cell. Oncol."},{"key":"2143_CR16","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1038\/jid.2012.63","volume":"132","author":"K Gowrishankar","year":"2012","unstructured":"Gowrishankar, K. et al. Acquired resistance to BRAF inhibition can confer cross-resistance to combined BRAF\/MEK inhibition. J. Invest. Dermatol. 132, 1850\u20131859 (2012).","journal-title":"J. Invest. Dermatol."},{"key":"2143_CR17","doi-asserted-by":"crossref","unstructured":"Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12, 1\u2013222 (2016).","DOI":"10.1080\/15548627.2015.1100356"},{"key":"2143_CR18","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1038\/jid.2015.329","volume":"135","author":"IV Fedorenko","year":"2015","unstructured":"Fedorenko, I. V., Wargo, J. A., Flaherty, K. T., Messina, J. L. & Smalley, K. S. M. BRAF inhibition generates a host\u2013tumor niche that mediates therapeutic escape. J. Invest. Dermatol. 135, 3115\u20133124 (2015).","journal-title":"J. Invest. Dermatol."},{"key":"2143_CR19","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian, S. L. et al. Safety, activity, and immune correlates of anti\u2013PD-1 antibody in cancer. N. Engl. J. Med. 366, 2443\u20132454 (2012).","journal-title":"N. Engl. J. Med."},{"key":"2143_CR20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi, F. S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711\u2013723 (2010).","journal-title":"N. Engl. J. Med."},{"key":"2143_CR21","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(17)31601-X","volume":"390","author":"J Schachter","year":"2017","unstructured":"Schachter, J. et al. Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006). Lancet 390, 1853\u20131862 (2017).","journal-title":"Lancet"},{"key":"2143_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrd.2015.35","volume":"15","author":"A Hoos","year":"2016","unstructured":"Hoos, A. Development of immuno-oncology drugs\u2014from CTLA4 to PD1 to the next generations. Nat. Rev. Drug Discov. 15, 235\u2013247 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2143_CR23","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.cell.2017.01.010","volume":"168","author":"W Hugo","year":"2017","unstructured":"Hugo, W. et al. Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell 168, 542 (2017).","journal-title":"Cell"},{"key":"2143_CR24","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072 (2012).","journal-title":"Cell"},{"key":"2143_CR25","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.02523","volume":"3","author":"SJ Dixon","year":"2014","unstructured":"Dixon, S. J. et al. Pharmacological inhibition of cystine\u2013glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife 3, e02523 (2014).","journal-title":"Elife"},{"key":"2143_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbrc.2016.10.086","volume":"482","author":"MM Gaschler","year":"2017","unstructured":"Gaschler, M. M. & Stockwell, B. R. Lipid peroxidation in cell death. Biochem. Biophys. Res. Commun. 482, 419\u2013425 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2143_CR27","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4049\/jimmunol.182.1.466","volume":"182","author":"IN Mungrue","year":"2009","unstructured":"Mungrue, I. N., Pagnon, J., Kohannim, O., Gargalovic, P. S. & Lusis, A. J. CHAC1\/MGC4504 is a novel proapoptotic component of the unfolded protein response, downstream of the ATF4-ATF3-CHOP cascade. J. Immunol. 182, 466\u2013476 (2009).","journal-title":"J. Immunol."},{"key":"2143_CR28","doi-asserted-by":"publisher","first-page":"15878","DOI":"10.1074\/jbc.M114.635144","volume":"290","author":"RR Crawford","year":"2015","unstructured":"Crawford, R. R. et al. Human CHAC1 protein degrades glutathione, and mRNA Induction is regulated by the transcription factors ATF4 and ATF3 and a bipartite ATF\/CRE regulatory element. J. Biol. Chem. 290, 15878\u201315891 (2015).","journal-title":"J. Biol. Chem."},{"key":"2143_CR29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/jb\/mvh122","volume":"136","author":"K Yamamoto","year":"2004","unstructured":"Yamamoto, K., Yoshida, H., Kokame, K., Kaufman, R. J. & Mori, K. Differential contributions of ATF6 and XBP1 to the activation of endoplasmic reticulum stress-responsive cis-acting elements ERSE, UPRE and ERSE-II. J. Biochem. 136, 343\u2013350 (2004).","journal-title":"J. Biochem."},{"key":"2143_CR30","doi-asserted-by":"publisher","unstructured":"Giglio, P. et al. PKR and GCN2 stress kinases promote an ER stress-independent eIF2\u03b1 phosphorylation responsible for calreticulin exposure in melanoma cells. Oncoimmunology (2018). https:\/\/doi.org\/10.1080\/2162402X.2018.1466765","DOI":"10.1080\/2162402X.2018.1466765"},{"key":"2143_CR31","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cbi.2014.09.024","volume":"234","author":"TM Penning","year":"2015","unstructured":"Penning, T. M. The aldo-keto reductases (AKRs): overview. Chem. Biol. Interact. 234, 236\u2013246 (2015).","journal-title":"Chem. Biol. Interact."},{"key":"2143_CR32","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.bbagen.2017.05.019","volume":"1861","author":"GO Latunde-Dada","year":"2017","unstructured":"Latunde-Dada, G. O. Ferroptosis: role of lipid peroxidation, iron and ferritinophagy. Biochim. Biophys. Acta - Gen. Subj. 1861, 1893\u20131900 (2017).","journal-title":"Biochim. Biophys. Acta - Gen. Subj."},{"key":"2143_CR33","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/03602530802431439","volume":"40","author":"OA Barski","year":"2008","unstructured":"Barski, O. A., Tipparaju, S. M. & Bhatnagar, A. The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. Drug Metab. Rev. 40, 553\u2013624 (2008).","journal-title":"Drug Metab. Rev."},{"key":"2143_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang, W. S. & Stockwell, B. R. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 26, 165\u2013176 (2016).","journal-title":"Trends Cell Biol."},{"key":"2143_CR35","first-page":"5405","volume":"15","author":"S Hao","year":"2018","unstructured":"Hao, S. et al. Metabolic networks in ferroptosis (Review). Oncol. Lett. 15, 5405\u20135411 (2018).","journal-title":"Oncol. Lett."},{"key":"2143_CR36","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1111\/cas.13380","volume":"108","author":"R Shintoku","year":"2017","unstructured":"Shintoku, R. et al. Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3. Cancer Sci. 108, 2187\u20132194 (2017).","journal-title":"Cancer Sci."},{"key":"2143_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.86","volume":"4","author":"J Xu","year":"2013","unstructured":"Xu, J. et al. Inhibition of 12\/15-lipoxygenase by baicalein induces microglia PPAR\u03b2\/\u03b4: a potential therapeutic role for CNS autoimmune disease. Cell Death Dis. 4, e569 (2013).","journal-title":"Cell Death Dis."},{"key":"2143_CR38","doi-asserted-by":"publisher","first-page":"13291","DOI":"10.1074\/jbc.R900010200","volume":"284","author":"T Nguyen","year":"2009","unstructured":"Nguyen, T., Nioi, P. & Pickett, C. B. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 284, 13291\u201313295 (2009).","journal-title":"J. Biol. Chem."},{"key":"2143_CR39","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1021\/acs.chemrestox.6b00319","volume":"30","author":"TM Penning","year":"2017","unstructured":"Penning, T. M. Aldo-keto reductase regulation by the Nrf2 system: implications for stress response, chemotherapy drug resistance, and carcinogenesis. Chem. Res. Toxicol. 30, 162\u2013176 (2017).","journal-title":"Chem. Res. Toxicol."},{"key":"2143_CR40","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1053\/j.gastro.2008.06.082","volume":"135","author":"T Shibata","year":"2008","unstructured":"Shibata, T. et al. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology 135, 1358\u20131368 (2008). 1368.e1\u20134.","journal-title":"Gastroenterology"},{"key":"2143_CR41","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/jid.2013.343","volume":"134","author":"S Miura","year":"2014","unstructured":"Miura, S. et al. A somatic mutation of the KEAP1 gene in malignant melanoma is involved in aberrant NRF2 activation and an increase in intrinsic drug resistance. J. Invest. Dermatol. 134, 553\u2013556 (2014).","journal-title":"J. Invest. Dermatol."},{"key":"2143_CR42","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1073\/pnas.1014275108","volume":"108","author":"D Ren","year":"2011","unstructured":"Ren, D. et al. Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Proc. Natl Acad. Sci. U. S. A. 108, 1433\u20131438 (2011).","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"2143_CR43","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ccell.2018.03.017","volume":"33","author":"J Tsoi","year":"2018","unstructured":"Tsoi, J. et al. Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress. Cancer Cell 33, 890\u2013904.e5 (2018).","journal-title":"Cancer Cell"},{"key":"2143_CR44","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1158\/1535-7163.MCT-08-1030","volume":"8","author":"DM Su","year":"2009","unstructured":"Su, D. M. et al. Two types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: implications for malignant melanoma therapy. Mol. Cancer Ther. 8, 1292\u20131304 (2009).","journal-title":"Mol. Cancer Ther."},{"key":"2143_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll, S. et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat. Chem. Biol. 13, 91\u201398 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"2143_CR46","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang, Z. et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45, W98\u2013W102 (2017).","journal-title":"Nucleic Acids Res."},{"key":"2143_CR47","doi-asserted-by":"crossref","first-page":"115164","DOI":"10.18632\/oncotarget.23046","volume":"8","author":"SH Hong","year":"2017","unstructured":"Hong, S. H. et al. Molecular crosstalk between ferroptosis and apoptosis: emerging role of ER stress-induced p53-independent PUMA expression. Oncotarget 8, 115164\u2013115178 (2017).","journal-title":"Oncotarget"},{"key":"2143_CR48","doi-asserted-by":"crossref","unstructured":"Corazzari, M., Gagliardi, M., Fimia, G. M. & Piacentini, M. Endoplasmic reticulum stress, unfolded protein response, and cancer cell fate. Front. Oncol. 7, 78 (2017).","DOI":"10.3389\/fonc.2017.00078"},{"key":"2143_CR49","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/iub.1616","volume":"69","author":"S Doll","year":"2017","unstructured":"Doll, S. & Conrad, M. Iron and ferroptosis: a still ill-defined liaison. IUBMB Life 69, 423\u2013434 (2017).","journal-title":"IUBMB Life"},{"key":"2143_CR50","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1158\/0008-5472.CAN-06-3481","volume":"67","author":"SR Alonso","year":"2007","unstructured":"Alonso, S. R. et al. A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis. Cancer Res. 67, 3450\u20133460 (2007).","journal-title":"Cancer Res."},{"key":"2143_CR51","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat. Cell Biol. 20, 1181\u20131192 (2018).","journal-title":"Nat. Cell Biol."},{"key":"2143_CR52","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ijc.24999","volume":"126","author":"WG Dirks","year":"2010","unstructured":"Dirks, W. G. et al. Cell line cross-contamination initiative: an interactive reference database of STR profiles covering common cancer cell lines. Int. J. Cancer 126, 303\u2013304 (2010).","journal-title":"Int. J. Cancer"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-2143-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-2143-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-2143-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T18:01:13Z","timestamp":1671213673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-2143-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,28]]},"references-count":52,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["2143"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-2143-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,28]]},"assertion":[{"value":"9 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"902"}}